Akorn Ch. 11 Plan Confirmed Over MDL Plaintiffs' Objection
A Delaware bankruptcy court confirmed the Chapter 11 plan of pharmaceutical company Akorn Inc. on Friday, saying objections from plaintiffs asserting antitrust claims against the debtor's leadership weren't enough to overcome...To view the full article, register now.
Already a subscriber? Click here to view full article